Ottimo Pharma

Pioneering bi-functional medicines to extend the lives of people living with cancer.

Founded
2020
Business Model
B2B
Last Round
SeedDec 2024
Rounds
2

About

Ottimo Pharma is a clinical-stage biotechnology company co-founded in 2020 by Medicxi and Jonny Finlay, developing pioneering PD-1/VEGFR2 dual-paratopic antibodies designed to extend the lives of cancer patients. The company emerged from stealth in October 2024 with backing from Medicxi and a management team led by Chair and CEO David Epstein, whose leadership team includes veterans from Merck, Gilead, and Amgen. Ottimo Pharma is a UK-registered private company focused on improving cancer treatment outcomes through a novel combination of mechanisms of action.

Summary

Ottimo Pharma is a Biotech company, founded in 2020. Its most recent funding was a Seed round in Dec 2024. Investors include Medicxi, OrbiMed and Avoro Ventures.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries ADec 2024

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ottimo Pharma on Indexed.vc
<a href="https://indexed.vc/companies/ottimo-pharma"><img src="https://indexed.vc/api/badge/company/ottimo-pharma" alt="Ottimo Pharma on Indexed.vc" width="260" height="76" /></a>